Zhejiang Haisen Pharmaceutical Co., Ltd. (SHE:001367)
China flag China · Delayed Price · Currency is CNY
23.66
0.00 (0.00%)
At close: May 6, 2026

SHE:001367 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Net Income
133.58135.88122.56104.67107.5994
Depreciation & Amortization
23.1823.1816.7913.4114.313.03
Other Amortization
0.850.850.491.991.681.71
Loss (Gain) From Sale of Assets
---0.24--
Asset Writedown & Restructuring Costs
0.40.41.230.961.210.67
Loss (Gain) From Sale of Investments
-6.71-6.71-3-0.323.85-1.45
Provision & Write-off of Bad Debts
2.732.730.090.431.09-0.27
Other Operating Activities
-10.751.120.61.6-7.454.29
Change in Accounts Receivable
-16.48-16.48-27.23-20.5611.11-22.35
Change in Inventory
-3.05-3.0537.64-19.1-38.88-20.63
Change in Accounts Payable
17.1717.1711.19-4.6-19.2936.22
Change in Other Net Operating Assets
20.7120.715.77-0.080.22-0.24
Operating Cash Flow
163.28177.45167.1680.6274.95107.04
Operating Cash Flow Growth
-12.23%6.16%107.35%7.56%-29.98%39.93%
Capital Expenditures
-114.38-152.26-64.75-57.44-20.19-33.32
Sale of Property, Plant & Equipment
---0.12-0
Investment in Securities
-92.23-144.9830.32-0.99-1.21
Investing Cash Flow
-206.61-297.25-61.75-57-21.18-34.52
Long-Term Debt Repaid
--1.72-1.86-1.04-1.15-0.88
Total Debt Repaid
-1.72-1.72-1.86-1.04-1.15-0.88
Net Debt Issued (Repaid)
-1.72-1.72-1.86-1.04-1.15-0.88
Issuance of Common Stock
3.583.5825.46698.45--
Common Dividends Paid
-17.45-17.45-34--0.71-16.43
Other Financing Activities
----24.08-1.9-1.4
Financing Cash Flow
-15.59-15.59-10.39673.33-3.77-18.71
Foreign Exchange Rate Adjustments
-0.380.912.680.615.52-1.46
Net Cash Flow
-59.3-134.4797.69697.5555.5252.35
Free Cash Flow
48.925.19102.4123.1754.7673.72
Free Cash Flow Growth
-45.01%-75.40%341.91%-57.68%-25.73%32.89%
Free Cash Flow Margin
9.38%4.73%21.72%5.83%12.95%18.95%
Free Cash Flow Per Share
0.320.170.690.170.490.66
Cash Income Tax Paid
7.198.9319.2733.385.2412.89
Levered Free Cash Flow
0.47-21.283.57-18.14-2.3544.27
Unlevered Free Cash Flow
0.69-20.9883.8-18.12-2.3144.34
Change in Working Capital
20.0120.0128.39-42.36-47.31-4.94
Source: S&P Global Market Intelligence. Standard template. Financial Sources.